Traws Pharma (TRAW) Stock Price, Quote, News & History | Benzinga

Traws Pharma Inc (TRAW) Stock Price, Quote, News & History

TRAWNASDAQ

Trade with Public

Trade with Public

$0.5899

0.00450.77%

At close: Aug 28, 5:00 PM EST

$0.5979

0.0081.36%

After Hours: 6:36 PM EST

OverviewNews Earnings Forecast Price Targets Financials Sentiment Ownership Compare Stock Report

Key Statistics

Open

$0.60

Close

$0.59

Volume / Avg.

43.98K / 289.22K

Day Range

$0.58 - $0.60

52 Wk Range

0.43 - 3.27

Market Cap

$9.19M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

52

Short Interest

4.78%

Days to Cover

6.39

Recent Traws Pharma Inc News

This Intuit Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Thursday

Wall Street analysts updated ratings for CURB, INTU, ENGN. See their outlooks and targets at Benzinga's analyst ratings page.

Avi Kapoor

Traws Pharma Stock Falls As UK Regulator Delays Key Flu Study

Traws Pharma shares fell after UK regulators deferred a planned influenza challenge study for tivoxavir marboxil, delaying clinical development.

Vandana Singh

Bandwidth, Traws Pharma And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Dow futures up 400 points; Bandwidth Inc (BAND) falls after $275M offering; other stocks declining in pre-market trading.

Avi Kapoor

Why Tower Semiconductor Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket

Tower Semiconductor (TSEM) jumped 4.7% in pre-market trading after announcing a multi-year supply agreement and resolving IP disputes. Other gainers include VS Media Holdings (VSME), Freecast Inc (CAST), and Cosmos Health Inc (COSM).

Avi Kapoor

Chuck Schumer Blasts Trump, Elon Musk For Firing CDC And Port Health Workers As Hantavirus Scare Grips The World

Hantavirus outbreak on a cruise ship sparks alarm as Schumer blames CDC cuts, warning weakened disease surveillance and calling for urgent reforms.

Snigdha Gairola

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-16.85M

Investing Cash Flow (TTM)

-

Financing Cash Flow (TTM)

11.38M

Free Cash Flow (TTM)

-19.43M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

-8.05M

Analyst Trends and Forecast

1

May

2

Jun

1

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.0

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$4.05M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

5.37

Earnings Yield % (TTM)

-309.75%

Earnings Yield % (FWD)

-187.88%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.11

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$5.02M

Debt to Equity

-

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$0.60

Close

$0.59

Volume / Avg.

43.98K / 289.22K

Day Range

$0.58 - $0.60

52 Wk Range

0.43 - 3.27

Market Cap

$9.19M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

52

Short Interest

4.78%

Days to Cover

6.39

About

Sector

Health Care

Industry

Pharmaceuticals

Traws Pharma Inc is a clinical-stage biopharmaceutical company dedicated to developing novel therapies to target critical threats to human health in respiratory viral diseases. It is advancing novel investigational antiviral agents that have potent a...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Traws Pharma (TRAW) stock?

A

You can purchase shares of Traws Pharma (NASDAQ:TRAW) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Traws Pharma (TRAW) competitors?

A

Other companies in Traws Pharma’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).

Q

What is the forecast, or price target, for Traws Pharma (TRAW) stock?

A

Traws Pharma has a consensus price target of $1.00.

Q

What is the current price for Traws Pharma (TRAW)?

A

The stock price for Traws Pharma (NASDAQ: TRAW) is $0.5979 last updated August 28, 2026 at 6:36 PM EDT.

Q

Does Traws Pharma (TRAW) pay a dividend?

A

There are no upcoming dividends for Traws Pharma.

Q

When is Traws Pharma (NASDAQ:TRAW) reporting earnings?

A

Traws Pharma does not have any upcoming earnings scheduled.

Q

Is Traws Pharma (TRAW) going to split?

A

There is no upcoming split for Traws Pharma.

Q

What sector and industry does Traws Pharma (TRAW) operate in?

A

Traws Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.